1-2 of 2
duration of treatment
Close
Save search
Sort by
Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Free
Clinical Trials & Observations
Catia Simoes, Bruno Paiva, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez, Maria-Belen Vidriales, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2021) 5 (3): 760–770.
https://doi.org/10.1182/bloodadvances.2020003195
Published: 2021
Includes: Supplemental data
Journal Articles

Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)

Free
Clinical Trials & Observations
Reza Mirza, Robby Nieuwlaat, Juan J. López-Núñez, Raquel Barba, Arnav Agarwal, Carme Font, Maurizio Ciammaichella, Elvira Grandone, Rick Ikesaka, Mark Crowther, Manuel Monreal, the RIETE Investigators
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2460–2467.
https://doi.org/10.1182/bloodadvances.2019001373
Published: 2020
Includes: Supplemental data